Physician profile
Eric J Moreau
NPI 1245663632
$1,550.14
in general payments reported to CMS, 2019-2025
11 companies · $86.00 in 2025
The $86.00 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $182 · 2021: $83.60 · 2022: $78.47 · 2023: $452 · 2024: $233 · 2025: $86.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $357.36 | 2022-2024 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $238.45 | 2019-2020 | |
| Alcon Vision LLC | $216.16 | 2019-2020 | |
| Coopervision INC. | $132.06 | 2021-2024 | Misight Contact Lens |
| Mallinckrodt Hospital Products INC. | $129.33 | 2023 | Acthar |
| Oyster Point Pharma, INC. | $124.99 | 2023 | Tyrvaya |
| Allergan, INC. | $101.33 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $86.00 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $82.25 | 2020-2023 | Cequa |
| Glaukos Corporation | $67.22 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.99 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Moreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.